Published in

Royal Society of Chemistry, Biomaterials Science, 13(8), p. 3720-3729, 2020

DOI: 10.1039/d0bm00556h

Links

Tools

Export citation

Search in Google Scholar

Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells

Journal article published in 2020 by Ana Baião ORCID, Flávia Sousa ORCID, Ana Vanessa Oliveira ORCID, Carla Oliveira ORCID, Bruno Sarmento ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

v6 Fab-PLGA-PEG NPs have the potential to deliver intracellularly bevacizumab in CD44v6 expressing cancer cells.